Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1989 Mar;82(3):145–146. doi: 10.1177/014107688908200310

Severe herpes zoster infection in the United Kingdom: experience in a regional infectious disease unit.

P Bannister 1, B Crosse 1
PMCID: PMC1292038  PMID: 2704012

Abstract

Seventy-three cases of severe herpes zoster infection admitted to a regional infectious disease unit over a 3-year period were reviewed. Complications were common. Elderly patients were in the majority (55%), were hospitalized for longer and accounted for 78% of all complications. Acyclovir therapy was used in 44 cases with a reduction in both the duration of hospital stay and complication rate.

Full text

PDF
145

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang C. M., Woo E., Yu Y. L., Huang C. Y., Chin D. Herpes zoster and its neurological complications. Postgrad Med J. 1987 Feb;63(736):85–89. doi: 10.1136/pgmj.63.736.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Esmann V., Ipsen J., Peterslund N. A., Seyer-Hansen K., Schønheyder H., Juhl H. Therapy of acute herpes zoster with acyclovir in the nonimmunocompromised host. Am J Med. 1982 Jul 20;73(1A):320–325. doi: 10.1016/0002-9343(82)90116-4. [DOI] [PubMed] [Google Scholar]
  3. Finn R., Smith M. A. Oral acyclovir for herpes zoster. Lancet. 1984 Sep 8;2(8402):575–575. doi: 10.1016/s0140-6736(84)90785-2. [DOI] [PubMed] [Google Scholar]
  4. HOPE-SIMPSON R. E. THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med. 1965 Jan;58:9–20. doi: 10.1177/003591576505800106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Harnisch J. P. Zoster in the elderly: clinical, immunologic and therapeutic considerations. J Am Geriatr Soc. 1984 Nov;32(11):789–793. doi: 10.1111/j.1532-5415.1984.tb06298.x. [DOI] [PubMed] [Google Scholar]
  6. Mazur M. H., Dolin R. Herpes zoster at the NIH: a 20 year experience. Am J Med. 1978 Nov;65(5):738–744. doi: 10.1016/0002-9343(78)90791-x. [DOI] [PubMed] [Google Scholar]
  7. McKendrick M. W., McGill J. I., Bell A. M., Hickmott E., Burke C. Oral acyclovir for herpes zoster. Lancet. 1984 Oct 20;2(8408):925–925. doi: 10.1016/s0140-6736(84)90678-0. [DOI] [PubMed] [Google Scholar]
  8. Miller A. E. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology. 1980 Jun;30(6):582–587. doi: 10.1212/wnl.30.6.582. [DOI] [PubMed] [Google Scholar]
  9. Ragozzino M. W., Melton L. J., 3rd, Kurland L. T., Chu C. P., Perry H. O. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982 Sep;61(5):310–316. doi: 10.1097/00005792-198209000-00003. [DOI] [PubMed] [Google Scholar]
  10. Ross C. A., Brown W. K., Clarke A., Caldwell W. F., Gordon E. R., Harvey J., McAlister A. M., McGlone J., Prentice R. T., Thorburn W. Herpes zoster in general practice. J R Coll Gen Pract. 1975 Jan;25(150):29–32. [PMC free article] [PubMed] [Google Scholar]
  11. Weller T. H. Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus. N Engl J Med. 1983 Dec 1;309(22):1362–1368. doi: 10.1056/NEJM198312013092205. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES